Geneos Wealth Management’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175K Sell
695
-2
-0.3% -$556 ﹤0.01% 1038
2026
Q1
$173K Sell
697
-59
-8% -$14K ﹤0.01% 1008
2025
Q4
$184K Buy
756
+718
+1,889% +$180K ﹤0.01% 951
2025
Q3
$10.6K Sell
38
-82
-68% -$22.9K ﹤0.01% 1945
2025
Q2
$34.7K Buy
120
+23
+24% +$6.23K ﹤0.01% 1758
2025
Q1
$24.6K Buy
97
+22
+29% +$5K ﹤0.01% 1851
2024
Q4
$15.5K Sell
75
-12
-14% -$2.26K ﹤0.01% 1846
2024
Q3
$16.5K Buy
87
+81
+1,350% +$14.6K ﹤0.01% 1632
2024
Q2
$1.07K Hold
6
– – ﹤0.01% 1972
2024
Q1
$1.14K Hold
6
– – ﹤0.01% 1993
2023
Q4
$1.24K Buy
+6
New +$1.25K ﹤0.01% 1987
2022
Q2
– Sell
-88
Closed -$19K – 2803
2022
Q1
$19K Sell
88
-289
-77% -$63K ﹤0.01% 1837
2021
Q4
$95K Buy
377
+300
+390% +$69.4K ﹤0.01% 1194
2021
Q3
$15K Hold
77
– – ﹤0.01% 2078
2021
Q2
$17K Hold
77
– – ﹤0.01% 2001
2021
Q1
$16K Sell
77
-2,009
-96% -$395K ﹤0.01% 2188
2020
Q4
$416K Buy
2,086
+830
+66% +$170K 0.02% 587
2020
Q3
$258K Sell
1,256
-115
-8% -$23.8K 0.01% 602
2020
Q2
$279K Buy
1,371
+216
+19% +$44.8K 0.02% 567
2020
Q1
$200K Buy
1,155
+871
+307% +$171K 0.01% 610
2019
Q4
$55K Buy
284
+254
+847% +$47.7K ﹤0.01% 1207
2019
Q3
$5K Hold
30
– – ﹤0.01% 2119
2019
Q2
$6K Hold
30
– – ﹤0.01% 2091
2019
Q1
$5K Hold
30
– – ﹤0.01% 2060
2018
Q4
$4K Hold
30
– – ﹤0.01% 2076
2018
Q3
$4K Hold
30
– – ﹤0.01% 2138
2018
Q2
$4K Hold
30
– – ﹤0.01% 2001
2018
Q1
$3K Hold
30
– – ﹤0.01% 1977
2017
Q4
$3K Buy
+30
New +$3.35K ﹤0.01% 1965
2017
Q3
– Sell
-17
Closed -$1K – 2156
2017
Q2
$1K Buy
+17
New +$1.53K ﹤0.01% 2036

Other funds holding VRSN

Geneos Wealth Management's VRSN Position: Q2 2026 in Review

Geneos Wealth Management reduced its VeriSign (VRSN) stake by 0.29% in Q2 2026, selling an estimated $556 and leaving 695 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Geneos Wealth Management first reported a position in VRSN in Q2 2017 and has held it in 30 quarters since. The position peaked at $416K in Q4 2020. 881 funds tracked by Wall St. Rank hold VRSN as of Q2 2026.

  • Geneos Wealth Management held 695 shares of VeriSign worth $175K as of Q2 2026.
  • Geneos Wealth Management sold 2 VeriSign shares in Q2 2026, an estimated $556.
  • VeriSign made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1038 holding.
  • Geneos Wealth Management first reported a position in VeriSign in Q2 2017 and has held it in 30 quarters since.
  • Geneos Wealth Management's VeriSign position peaked at $416K in Q4 2020.
  • 881 funds tracked by Wall St. Rank held VeriSign as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.